CD8A and colorectal cancer: confirmed that HMGA2 reduced the sensitivity of colorectal cancer (CRC) cells to CD8+-T cell-mediated cytotoxicity through the miRNA-200c-3p/LSAMP/Wnt axis, promoting tumor development (39).